Integrative Mindfulness-Based Predictive Approach for Chronic Low Back Pain Treatment
IMPACT
2 other identifiers
interventional
350
1 country
1
Brief Summary
This study will identify unique signatures that people have which can cause pain by evaluating biological, psychological, and social markers using artificial intelligence. These markers can be used to accurately predict the response of diverse individuals with chronic low back pain (cLBP) to Mindfulness-Based Stress Reduction. This will help enhance clinician decision-making and the targeted treatment of chronic pain. The overall objective is to use a unique machine learning (ML) approach to determine the biomarker signature of persons undergoing mindfulness based stress reduction (MBSR) treatment for their chronic low back pain (cLBP). This signature will facilitate clinical prediction and monitoring of patient response to MBSR treatment. The design of the study is a single-arm clinical trial of the evidence-based MBSR program for patients with cLBP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2023
CompletedFirst Posted
Study publicly available on registry
October 30, 2023
CompletedStudy Start
First participant enrolled
July 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
June 26, 2025
June 1, 2025
4.1 years
October 24, 2023
June 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain, Enjoyment, General activity (PEG) composite score
The PEG is a 3-question scale: "pain average", "interference with general activity" and "interference with enjoyment of life". Each question is on a 0-10 scale, and total PEG is the average. Scores can range from 0-30 and \<12=Mild,12 to \<21 = Moderate, 21 to 30 = Severe chronic pain.
6 months
Secondary Outcomes (11)
Depression assessed by the eight-item Patient Health Questionnaire for Depression (PHQ-8)
baseline, 4 weeks, 8 weeks, 4 months, 6 months
Anxiety assessed by the Generalized Anxiety Disorder-7 (GAD-7)
baseline, 4 weeks, 8 weeks, 4 months, 6 months
Pain Self-Efficacy assessed by the Pain Self-Efficacy Questionnaire
baseline, 4 weeks, 8 weeks, 4 months, 6 months
Catastrophizing assessed by the Pain Catastrophizing Scale Short Form
baseline, 4 weeks, 8 weeks, 4 months, 6 months
Quality of Life assessed by the Patient Reported Outcomes Measurement Information System (PROMIS 29)
baseline, 4 weeks, 8 weeks, 4 months, 6 months
- +6 more secondary outcomes
Study Arms (1)
Mindfulness based stress reduction (MBSR) program
EXPERIMENTALParticipants will be enrolled in a 8-week mindfulness clinical pain program + Primary Care Provider (PCP) Usual Care.
Interventions
Ordinary activities like breathing, eating, and walking are turned into a meditation by creating greater awareness of the moment-to-moment sensations, emotions, thoughts and behaviors that arise during these activities.
Understanding pain from a mind-body perspective and viewing pain as a stressor on physical sensations, thoughts, emotions, and behavior.
Discussion on patients' use of mindfulness to work with pain and pain-themed meditations.
Eligibility Criteria
You may qualify if:
- Chronic low back pain, which is pain that persists for at least 3-months and has resulted in pain on at least half the days in the past 6 months
- Willing and able to provide online or telephone informed consent
- Speak English as the intervention manual is currently written in English
You may not qualify if:
- Red flags- recent (past month) worsening of pain, unexplained fever, unexplained weight loss
- Pregnancy
- Metastatic cancer
- Not a patient at a participating clinic or persons not planning to continue as a patient at a participating clinic for 6 or more months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Medical Center
Boston, Massachusetts, 02116, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Natalia Morone, MD MS
Boston Medical Center
- PRINCIPAL INVESTIGATOR
Jean King, PhD
Worcester Polytechnic Institute
- PRINCIPAL INVESTIGATOR
Emmanuel Agu, PhD
Worcester Polytechnic Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 24, 2023
First Posted
October 30, 2023
Study Start
July 25, 2024
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
December 1, 2029
Last Updated
June 26, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share